ClinicalThought

Share

Program Content

Activities

  • FAQs: CAR T-Cell Tx in Lymphomas
    Experts Answer Questions on Integrating CAR T-Cell Therapy Into the Management of DLBCL, FL, MCL, and CLL/SLL to Improve Outcomes
    Clinical Thought
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 27, 2023

Faculty

cover img faculity

Michael R. Bishop, MD

Professor of Medicine, Director
Section of Hematology/Oncology,
Cellular Therapy Program
University of Chicago
Chicago, Illinois

cover img faculity

Kathleen Dorritie, MD

Assistant Professor of Medicine
Division of Hematology/Oncology
UPMC Hillman Cancer Center,
University of Pittsburgh
Pittsburgh, Pennsylvania

cover img faculity

Julie M. Vose, MD, MBA

Newmann M. and Milde E. Harris Professor
Chief, Hematology/Oncology
Department of Internal Medicine
University of Nebraska Medical Center
Omaha, Nebraska

Provided by

ProCE Banner

Supporters

Supported by an educational grant from Bristol Myers Squibb.

Bristol Myers Squibb